Big Pharma Split Corp. (PRM.TO) TSX
Currency In CAD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 17.04M |
| Enterprise Value | 28.85M |
| P/E Ratio | 2.98 |
| PEG Ratio | 0.01 |
| Price/Sales Ratio | 5.65 |
| Price/Book Ratio | 1.1 |
| Enterprise/Revenue | 8.83 |
| Enterprise/EBITDA | 6.38 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 1.79 |
| Operating Margin | 2.33 |
AD
Management Effectiveness
| Return On Assets | 0.2 |
| Return On Equity | 0.36 |
Income Statement
| Revenue | 1.45M |
| Revenue/Share | 2.86 |
| Gross Profit | 1.14M |
| EBITDA | 5.03M |
| Net Income | 4.4M |
| Diluted EPS | 3.59 |
Balance Sheet
| Total Cash | 1.07M |
| Total Cash/Share | 0.81 |
| Total Debt | 13.05M |
| Total Debt/Equity | 0.67 |
| Current Ratio | 0.09 |
| Book Value Per Share | 14.76 |
Price History
| 52-Week Change | 26.56 |
| 52-Week High | 16.2 |
| 52-Week Low | 12.83 |
| Moving Average 50 Days | 14.99 |
| Moving Average 200 Days | 14.44 |
Statistics
| Average Volume | 1,458 |
| Shares Outstanding | 1.31M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 1.24 |
| Trailing Annual Dividend Yield | 7.64 |
| Payout Ratio | 0.28 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
